PAR24 COST-UTILITY ANALYSIS OF RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS AFTER ANTI-TNF-ALFATHERAPY IN HUNGARY
V Brodszky, M Péntek, K Karpati, I Boncz, A Sebestyén, L GulácsiVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)64939-x
File:
PDF, 71 KB
english, 2007